- Zacks•51 minutes ago
Amgen Inc. (AMGN), along with partner Allergan plc. (AGN), announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ABP 215.
- TheStreet.com•21 hours ago
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||146.04 x 200|
|Ask||146.10 x 100|
|Day's Range||144.42 - 146.31|
|52 Week Range||133.64 - 176.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||14.62|
|Dividend & Yield||4.00 (2.78%)|
|1y Target Est||N/A|